Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects After COVID-19 Vaccination”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)UnknownNCT05200754
What this trial is testing

Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Carsten Müller-Tidow 174
Not applicableStudy completedNCT05470894
What this trial is testing

Liver Injury After COVID-19 Vaccination

Who this might be right for
Subjects After COVID-19 Vaccination
Humanity & Health Medical Group Limited 379
Not applicableUnknownNCT04944095
What this trial is testing

Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations

Who this might be right for
Covid-19Subjects Vaccinated Against Covid-19
Dr. Sidney J. Stohs 10,000
Early research (Phase 1)Study completedNCT04563702
What this trial is testing

Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects

Who this might be right for
Covid19
Vaxart 35

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation